Genentech has stopped developing emugrobart after trial results showed no consistent benefit when added to Evrysdi in people ...

In 2018, when Nell Choi was 9 years old, she began experiencing symptoms that led to hospitalization and a diagnosis of ...

Columnist Sherry Toh usually cringes at people who stare, but a performative art project taught her something new about ...

The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial ...

Up to three years of Evrysdi treatment appears safe and may help presymptomatic children with SMA reach and maintain key milestones.

High doses of Spinraza may help stabilize or improve motor function for many people with SMA, per pooled clinical trial ...

Columnist Ari Anderson recently enjoyed six weeks free from searching for new members of his nursing staff. Now, he's aiming ...

Biogen has launched a trio of Phase 3 trials to test salanersen, a new SMA treatment that aims to be a more convenient ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google It is always an interesting and fun challenge to navigate my ...

Mutations that cause spinal muscular atrophy (SMA) may lead to abnormalities in the development of cells in the spinal cord, a study found.